COPEGUS Side Effects

6971002-6 | Diabetic Ketoacidosis, Pneumomediastinum
on Sep 01, 2010 Female patient from JAPAN , 69 years of age, weighting 90.39 lb, was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: diabetic ketoacidosis, pneumomediastinum. Copegus dosage: Note: Dosage Is Uncertain.. During the same period patient was treated with PEG INTRON (Note: Dosage Is Uncertain.) (View Peg-intron Review and Peg-intron Label ). Patient was hospitalized.

6965725-2 | Nephropathy
Patient was taking Copegus (View Usage). Patient had the following side effects: nephropathy on Aug 27, 2010 from CAMEROON Additional patient health information: Male patient , 60 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Copegus dosage: Dose:1000 Mg/day, Frequency: Bd.. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), COZAAR (View Cozaar Review and Cozaar Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6955603-7 | Congenital Anomaly, Congenital Intestinal Malformation, Gastroschisis, Intestinal Atresia, Premature Baby
Adverse event was reported on Aug 25, 2010 by a Female patient taking Copegus (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 4.85 lb, After Copegus was administered, patient had the following side effects: congenital anomaly, congenital intestinal malformation, gastroschisis, intestinal atresia, premature baby. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), EFFEXOR (View Effexor Review and Effexor Label ), ZOMIG (Formulation: Orodisp Tablet) (View Zomig Review and Zomig Label ), HALF INDERAL LA (View Half-inderal La Review and Half-inderal La Label ), NULYTELY (View Nulytely Review and Nulytely Label ), ACETAMINOPHEN (Dosing Freq: Prn) (View Acetaminophen Review and Acetaminophen Label ), HYDROCORTISONE CREAM (Taken During Hcv Treatment) (View Hydrocortisone Cream Review and Hydrocortisone Cream Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ).

6923183-8 | Type 1 Diabetes Mellitus
on Aug 04, 2010 Female patient from JAPAN , 68 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: type 1 diabetes mellitus. Copegus dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ), PEG INTRON (View Peg-intron Review and Peg-intron Label ), INSULIN (Note: Dosage Is Uncertain.) (View Insulin Review and Insulin Label ). Patient was hospitalized.


6887698-3 | Idiopathic Thrombocytopenic Purpura, Insomnia
on Jul 21, 2010 Male patient from JAPAN , weighting 134.5 lb, was diagnosed with insomnia and was treated with Copegus (View Usage). Patient had the following side effects: idiopathic thrombocytopenic purpura, insomnia. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), HALCION (View Halcion Review and Halcion Label ), DEPAS (View Depas Review and Depas Label ).

6815603-4 | Hepatic Neoplasm Malignant, Type 1 Diabetes Mellitus
Patient was taking Copegus (View Usage). After Copegus was administered, patient had the following side effects: hepatic neoplasm malignant, type 1 diabetes mellitus on Jun 23, 2010 from JAPAN Additional patient health information: Female patient , 68 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Copegus dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ), PEG INTRON (Note: Dosage Is Uncertain) (View Peg-intron Review and Peg-intron Label ).

6780222-5 | Haemangioma Congenital
Adverse event was reported on May 28, 2010 by a Female patient taking Copegus (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: GERMANY , weighting 7.50 lb, Patient experienced the following unwanted or unexpected effects: haemangioma congenital. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

6767744-8 | Sepsis
on Jun 02, 2010 Male patient from GERMANY , weighting 154.3 lb, was diagnosed with hepatitis c (What is hepatitis c?), immunosuppression and was treated with Copegus (View Usage). Patient had the following side effects: sepsis (What is sepsis?). Copegus dosage: 3-0-3. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), CERTICAN (1-0-1) (View Certican Review and Certican Label ), PANTOZOL (0-0-1) (View Pantozol Review and Pantozol Label ), ACTONEL (1-0-0) (View Actonel Review and Actonel Label ), FUROSEMIDE (1-0-0) (View Furosemide Review and Furosemide Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), CHOLESTYRAMINE (View Cholestyramine Review and Cholestyramine Label ), DOCITON (View Dociton Review and Dociton Label ).

6751487-0 | Sepsis
on May 21, 2010 Male patient from GERMANY , weighting 154.3 lb, was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: sepsis (What is sepsis?). Copegus dosage: 3-0-3. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), CERTICAN (1-0-1) (View Certican Review and Certican Label ), PANTOPRAZOLE SODIUM (0-0-1) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ACTONEL (1-0-0) (View Actonel Review and Actonel Label ), FUROSEMIDE (1-0-0) (View Furosemide Review and Furosemide Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), CHOLESTYRAMINE (View Cholestyramine Review and Cholestyramine Label ).

6749319-X | Retinal Vein Occlusion
Patient was taking Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: retinal vein occlusion on May 25, 2010 from JAPAN Additional patient health information: Female patient , weighting 88.18 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), JUVELA (Note: Dosage Is Uncertain.) (View Juvela Review and Juvela Label ), NORVASC (Note: Dosage Is Uncertain.) (View Norvasc Review and Norvasc Label ), CANDESARTAN CILEXETIL (Note: Dosage Is Uncertain.) (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), THYRADIN (View Thyradin Review and Thyradin Label ).

6736050-X | Congenital Anomaly, Congenital Intestinal Malformation, Intestinal Atresia
Adverse event was reported on May 17, 2010 by a Female patient taking Copegus (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 4.85 lb, Patient had the following side effects: congenital anomaly, congenital intestinal malformation, intestinal atresia. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), EFFEXOR (View Effexor Review and Effexor Label ), ZOMIG (Formulation: Orodisp Tablet) (View Zomig Review and Zomig Label ), HALF INDERAL LA (View Half-inderal La Review and Half-inderal La Label ), NULYTELY (View Nulytely Review and Nulytely Label ), PARACETAMOL (Dosing Freq: Prn) (View Paracetamol Review and Paracetamol Label ), HYDROCORTISONE CREAM (Taken During Hcv Treatment) (View Hydrocortisone Cream Review and Hydrocortisone Cream Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ).

6692028-6 | Penile Ulceration
on Apr 14, 2010 Male patient from JAPAN , 61 years of age, was diagnosed with hepatitis (What is hepatitis?), hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: penile ulceration. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

6690236-1 | Congenital Anomaly, Congenital Intestinal Malformation, Intestinal Atresia
on Apr 19, 2010 Female patient from UNITED KINGDOM , weighting 4.85 lb, was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: congenital anomaly, congenital intestinal malformation, intestinal atresia. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), EFFEXOR (View Effexor Review and Effexor Label ), ZOMIG (Formulation: Orodisp Tablet) (View Zomig Review and Zomig Label ), HALF INDERAL LA (View Half-inderal La Review and Half-inderal La Label ), MOVICOL (View Movicol Review and Movicol Label ), PARACETAMOL (Dosing Freq: Prn) (View Paracetamol Review and Paracetamol Label ), HYDROCORTISONE CREAM (Taken During Hcv Treatment) (View Hydrocortisone Cream Review and Hydrocortisone Cream Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ).

6681119-1 | Congenital Anomaly, Congenital Intestinal Malformation, Intestinal Atresia
Patient was taking Copegus (View Usage). Patient had the following side effects: congenital anomaly, congenital intestinal malformation, intestinal atresia on Apr 06, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 4.85 lb, . Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), EFFEXOR (View Effexor Review and Effexor Label ), ZOMIG (Formulation: Orodisp Tablet) (View Zomig Review and Zomig Label ), HALF INDERAL LA (View Half-inderal La Review and Half-inderal La Label ), MOVICOL (View Movicol Review and Movicol Label ), PARACETAMOL (Dosing Freq: Prn) (View Paracetamol Review and Paracetamol Label ), HYDROCORTISONE CREAM (Taken During Hcv Treatment) (View Hydrocortisone Cream Review and Hydrocortisone Cream Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ).

6679395-4 | Arthralgia, Contusion, Decreased Appetite, Diarrhoea, Eczema Asteatotic, Headache, Hypoaesthesia, Insomnia, Loss Of Consciousness
Adverse event was reported on Apr 08, 2010 by a Female patient taking Copegus (View Usage) (Dosage: Action Taken: Discontinued) . Location: JAPAN , weighting 100.3 lb, After Copegus was administered, patient had the following side effects: arthralgia, contusion, decreased appetite, diarrhoea, eczema asteatotic, headache (What is headache?), hypoaesthesia, insomnia, loss of consciousness. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), LENDORMIN (Note: Amount Of One Time Of Single Use: 0.125-0.25mg Frequency: Taken As Needed.) (View Lendormin Review and Lendormin Label ). Patient was hospitalized.

6668897-2 | Arthralgia, Contusion, Decreased Appetite, Eczema Asteatotic, Headache, Hypoaesthesia, Insomnia, Loss Of Consciousness, Malaise
on Mar 30, 2010 Female patient from JAPAN , weighting 100.3 lb, was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, contusion, decreased appetite, eczema asteatotic, headache (What is headache?), hypoaesthesia, insomnia, loss of consciousness, malaise. Copegus dosage: Action Taken: Discontinued. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), LENDORMIN (Note: Amount Of One Time Of Single Use: 0.125-0.25mg) (View Lendormin Review and Lendormin Label ). Patient was hospitalized.

6654571-5 | Pulmonary Fibrosis
on Mar 18, 2010 Male patient from JAPAN , weighting 132.3 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). Patient had the following side effects: pulmonary fibrosis (What is pulmonary fibrosis?). Copegus dosage: Note: Divided Into 2 Doses. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), METHAPHYLLIN (View Methaphyllin Review and Methaphyllin Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ATENENTOIN (Form: Granulated Powder) (View Atenentoin Review and Atenentoin Label ), URSO 250 (Dose Form: Oral Formulation (not Otherwise Specified), Form: Peroral Agent) (View Urso 250 Review and Urso 250 Label ), VITADAN (View Vitadan Review and Vitadan Label ), RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ).

6646704-1 | Aortic Dissection, Cardiac Failure Acute
Patient was taking Copegus (View Usage). After Copegus was administered, patient had the following side effects: aortic dissection, cardiac failure acute on Mar 10, 2010 from JAPAN Additional patient health information: Male patient , 60 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

6633069-4 | Grand Mal Convulsion, Muscle Spasms, Ventricular Fibrillation
Adverse event was reported on Mar 04, 2010 by a Male patient taking Copegus (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: SWEDEN , 52 years of age, Patient experienced the following unwanted or unexpected effects: grand mal convulsion, muscle spasms, ventricular fibrillation. During the same period patient was treated with METADON (View Metadon Review and Metadon Label ). Patient was hospitalized.

6628291-7 | Multiple Sclerosis
on Mar 01, 2010 Female patient from JAPAN , 65 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). Patient had the following side effects: multiple sclerosis (What is multiple sclerosis?). Copegus dosage: Note: Uncertainty. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

6613631-5 | Cardiac Arrest, Grand Mal Convulsion, Haematoma, Muscle Spasms
on Feb 23, 2010 Male patient from SWEDEN , 52 years of age, was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), grand mal convulsion, haematoma, muscle spasms. Copegus dosage: . Patient was hospitalized.

6610024-1 | Skin Ulcer
Patient was taking Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: skin ulcer on Feb 17, 2010 from JAPAN Additional patient health information: Male patient , 71 years of age, . Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

6609971-6 | Pulmonary Fibrosis
Adverse event was reported on Feb 19, 2010 by a Male patient taking Copegus (View Usage) (Dosage: Note: Divided Into 2 Doses) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , weighting 132.3 lb, Patient had the following side effects: pulmonary fibrosis (What is pulmonary fibrosis?). During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), METHAPHYLLIN (View Methaphyllin Review and Methaphyllin Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), ATENENTOIN (Form: Granulated Powder) (View Atenentoin Review and Atenentoin Label ), URSO 250 (Dose Form: Oral Formulation (not Otherwise Specified), Form: Peroral Agent) (View Urso 250 Review and Urso 250 Label ), VITADAN (View Vitadan Review and Vitadan Label ), RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ).

6596186-3 | Delirium
on Feb 16, 2010 Male patient from JAPAN , 40 years of age, was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: delirium. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6577755-3 | Deafness
on Feb 08, 2010 Male patient from UNITED STATES , weighting 6.61 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: deafness. Copegus dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ), IRON (View Iron Review and Iron Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ).

6576773-9 | Asthenia, Back Pain, Dizziness, Headache, Pain In Extremity
Patient was taking Copegus (View Usage). Patient had the following side effects: asthenia, back pain (What is back pain?), dizziness (What is dizziness?), headache (What is headache?), pain in extremity on Feb 02, 2010 from PORTUGAL Additional patient health information: Male patient , 44 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Copegus dosage: . During the same period patient was treated with PEGASYS (Route: Injection, Dosage: One Injection (dose Not Provided)) (View Pegasys Review and Pegasys Label ).

6575247-9 | Deafness
Adverse event was reported on Jan 29, 2010 by a Male patient taking Copegus (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 6.61 lb, After Copegus was administered, patient had the following side effects: deafness. During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ), IRON NOS (View Iron Nos Review and Iron Nos Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ).

6568179-3 | Pulmonary Fibrosis
on Jan 26, 2010 Male patient from JAPAN , weighting 132.3 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary fibrosis (What is pulmonary fibrosis?). Copegus dosage: Note: Divided Into 2 Doses. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), METHAPHYLLIN (View Methaphyllin Review and Methaphyllin Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ATENENTOIN (View Atenentoin Review and Atenentoin Label ), URSO 250 (Dose Form: Oral Formulation (not Otherwise Specified)) (View Urso 250 Review and Urso 250 Label ), VITADAN (View Vitadan Review and Vitadan Label ), RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ).

6557939-0 | Blood Urine Present, Chest Pain, Condition Aggravated, Decreased Appetite, Dehydration, Diarrhoea, Dizziness, Dyspnoea, Fatigue
on Jan 14, 2010 Male patient from UNITED STATES , weighting 214.1 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). Patient had the following side effects: blood urine present, chest pain (What is chest pain?), condition aggravated, decreased appetite, dehydration, diarrhoea, dizziness (What is dizziness?), dyspnoea, fatigue. Copegus dosage: See Image. During the same period patient was treated with PEGASYS ((180 Ug, 1x/week Subcutaneous), (180 Ug 1x/week Subcutaneous)) (View Pegasys Review and Pegasys Label ), ALINIA ((500 Mg, Daily Oral), (500 Mg, Daily Oral)) (View Alinia Review and Alinia Label ), TRUVADA (View Truvada Review and Truvada Label ), BENADRYL /00673901/ (View Benadryl /00673901/ Review and Benadryl /00673901/ Label ), NORCO (View Norco Review and Norco Label ). Patient was hospitalized.

6555501-7 | Cardiac Failure, Dyspnoea, Pleural Effusion
Patient was taking Copegus (View Usage). After Copegus was administered, patient had the following side effects: cardiac failure, dyspnoea, pleural effusion on Jan 21, 2010 from FRANCE Additional patient health information: Male patient , 50 years of age, was diagnosed with hepatitis c (What is hepatitis c?), liver transplant (What is liver transplant?) and. Copegus dosage: . During the same period patient was treated with VIRAFERONPEG (View Viraferonpeg Review and Viraferonpeg Label ), PROGRAF (View Prograf Review and Prograf Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6541564-1 | Cardiac Failure, Neutrophil Count Decreased
Adverse event was reported on Jan 14, 2010 by a Male patient taking Copegus (View Usage) (Dosage: Dose Decreased) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure, neutrophil count decreased. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), DEPAS (View Depas Review and Depas Label ), MYSLEE (View Myslee Review and Myslee Label ), OMEPRAL (View Omepral Review and Omepral Label ). Patient was hospitalized.

6521432-1 | Cardiac Failure, Neutrophil Count Decreased, White Blood Cell Count Decreased
on Dec 24, 2009 Male patient from JAPAN , 61 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). Patient had the following side effects: cardiac failure, neutrophil count decreased, white blood cell count decreased. Copegus dosage: . During the same period patient was treated with PEGASYS (Frequency: /1 Week (s), Note: Uncertainty.) (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6517572-3 | Cardiac Failure
on Dec 14, 2009 Male patient from JAPAN , 61 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: cardiac failure. Copegus dosage: . During the same period patient was treated with PEGASYS (Frequency: /1 Week (s), Note: Uncertainty.) (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6473778-3 | Placenta Praevia, Premature Rupture Of Membranes
Patient was taking Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: placenta praevia, premature rupture of membranes on Nov 23, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 6.83 lb, was diagnosed with hepatitis c (What is hepatitis c?), asthma (What is asthma?) and. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), ABILIFY (View Abilify Review and Abilify Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6466305-8 | Cardiac Failure, Dyspnoea, Pleural Effusion
Adverse event was reported on Nov 20, 2009 by a Male patient taking Copegus (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: FRANCE , 50 years of age, Patient had the following side effects: cardiac failure, dyspnoea, pleural effusion. During the same period patient was treated with VIRAFERONPEG (View Viraferonpeg Review and Viraferonpeg Label ), PROGRAF (View Prograf Review and Prograf Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6457844-4 | Delirium
on Nov 12, 2009 Male patient from JAPAN , 40 years of age, was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: delirium. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6453394-X | Blister, Oedema Peripheral
on Nov 10, 2009 Female patient from UNITED KINGDOM , weighting 149.9 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: blister, oedema peripheral. Copegus dosage: . During the same period patient was treated with PEGYLATED INTERFERON NOS (View Pegylated Interferon Nos Review and Pegylated Interferon Nos Label ).

6433755-5 | Lymph Node Tuberculosis
Patient was taking Copegus (View Usage). Patient had the following side effects: lymph node tuberculosis on Oct 28, 2009 from JAPAN Additional patient health information: Male patient , 50 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Copegus dosage: . During the same period patient was treated with INTRON A (Dose: 1.5 Mu, Route: Injectable (not Otherwise Specified)) (View Intron A Review and Intron A Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), GRAN (Route: Injectable (not Otherwise Specified)) (View Gran Review and Gran Label ). Patient was hospitalized.

6424477-5 | Deafness
Adverse event was reported on Oct 21, 2009 by a Male patient taking Copegus (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 6.61 lb, After Copegus was administered, patient had the following side effects: deafness. During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ), IRON NOS (View Iron Nos Review and Iron Nos Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ).

6389473-5 | Congenital Torticollis, Polyhydramnios, Premature Labour, Umbilical Cord Vascular Disorder
on Sep 24, 2009 Female patient from UNITED STATES , weighting 4.19 lb, was diagnosed with diabetes mellitus, pregnancy (What is pregnancy?) and was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: congenital torticollis, polyhydramnios, premature labour, umbilical cord vascular disorder. Copegus dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ), HUMALOG (1 Dose In The Morning, 1 Dose In The Evening.) (View Humalog Review and Humalog Label ), HUMULIN R (Reported As Humilin.) (View Humulin R Review and Humulin R Label ), INSULIN (View Insulin Review and Insulin Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ).

6389472-3 | Cardiac Murmur, Polydactyly, Tooth Development Disorder
on Sep 24, 2009 Female patient from UNITED STATES , weighting 8.16 lb, was treated with Copegus (View Usage). Patient had the following side effects: cardiac murmur, polydactyly, tooth development disorder. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

6384135-2 | Anaemia, Retinal Haemorrhage, Thrombocytopenia
Patient was taking Copegus (View Usage). After Copegus was administered, patient had the following side effects: anaemia, retinal haemorrhage, thrombocytopenia on Sep 21, 2009 from GERMANY Additional patient health information: Male patient , weighting 141.1 lb, was diagnosed with hepatitis c (What is hepatitis c?), depression (What is depression?), panic disorder (What is panic disorder?) and. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ).

6379688-4 | Delirium
Adverse event was reported on Sep 01, 2009 by a Male patient taking Copegus (View Usage) (Dosage: ) . Location: JAPAN , 40 years of age, Patient experienced the following unwanted or unexpected effects: delirium. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6378735-3 | Gastric Cancer
on Sep 15, 2009 Female patient from JAPAN , 67 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). Patient had the following side effects: gastric cancer. Copegus dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ).

6366473-2 | Cardiac Failure Acute
on Sep 08, 2009 Male patient from JAPAN , 60 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: cardiac failure acute. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

6360854-9 | Dysuria
Patient was taking Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: dysuria on Sep 11, 2009 from JAPAN Additional patient health information: Male patient , 78 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6349510-0 | Overdose, Transfusion
Adverse event was reported on Aug 28, 2009 by a Female patient taking Copegus (View Usage) (Dosage: Possible Overdose; 4 Tablets In Am And 6 In Pm) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 49 years of age, Patient had the following side effects: overdose, transfusion. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PROCARDIA (View Procardia Review and Procardia Label ), ANAPRIL (View Anapril Review and Anapril Label ), NEXIUM (View Nexium Review and Nexium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6315042-9 | Anaemia, Thrombophlebitis
on Aug 06, 2009 Female patient from ROMANIA , weighting 143.3 lb, was diagnosed with essential hypertension and was treated with Copegus (View Usage). After Copegus was administered, patient had the following side effects: anaemia, thrombophlebitis. Copegus dosage: . During the same period patient was treated with NEORECORMON (Dose : 40000 U) (View Neorecormon Review and Neorecormon Label ), PEGASYS (View Pegasys Review and Pegasys Label ), PRESTARIUM (View Prestarium Review and Prestarium Label ).

6311690-0 | Acute Respiratory Distress Syndrome, Disseminated Intravascular Coagulation
on Aug 05, 2009 Female patient from JAPAN , 50 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Copegus (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, disseminated intravascular coagulation. Copegus dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ).

6303117-X | Endophthalmitis, Uveitis
Patient was taking Copegus (View Usage). Patient had the following side effects: endophthalmitis, uveitis on Jul 29, 2009 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Copegus dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.